Vonoprazan to prevent ulcers after variceal banding
Treatments studied
Part of Digestive system clinical trials.
This trial tests whether vonoprazan can reduce ulcers caused by a procedure that ties off enlarged veins in the esophagus (variceal band ligation). It is meant for people with liver cirrhosis who are scheduled to receive this treatment.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 to 75 years old
- You have liver cirrhosis confirmed by a doctor or imaging
- You have enlarged veins in your esophagus that need to be tied off
- You can give permission in English or Urdu
- You are willing to take the study medicine and attend follow-up exams
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests two different acid-reducing medicines (rabeprazole and vonoprazan) to see which one better prevents painful ulcers that can develop after a procedure to tie off bleeding veins in the esophagus. If you have cirrhosis and bleeding veins, this trial may help protect your healing.
This trial tests whether a heartburn medication (pantoprazole) helps patients with liver cirrhosis who have had a procedure to treat enlarged veins in the esophagus or stomach. It looks at how well the medicine works when given after this procedure to prevent complications.
This trial tests a medicine called vonoprazan for people whose acid reflux symptoms (like heartburn or coughing) don't get better with usual treatment. It aims to see if vonoprazan can help control those symptoms.
This study tests whether taking a proton pump inhibitor (a medicine that lowers stomach acid) helps people with liver cirrhosis who have sudden bleeding from enlarged esophagus veins (varices). It may help reduce bleeding and complications by changing stomach/upper digestive tract conditions during this urgent time.
This trial compares two approaches to prevent future bleeding from enlarged veins in the esophagus (food pipe) in patients with liver cirrhosis who have already had one bleeding episode. You'll receive either an endoscopic procedure with medication or a minimally invasive vein procedure, to see which works better long-term.
This trial tests a new heartburn medicine called vonoprazan (10 mg) compared to a placebo (sugar pill) for people with chronic heartburn but no damage to the esophagus. If you have heartburn at least 4 days a week, you may be able to try this once-daily pill for 24 weeks.
Hear when a new Cirrhoses, Liver trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.